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Background: Metabolic syndrome (MetS) and type 2 diabetes mellitus in humans are associated 
with increased platelet activation and hyperreactivity of platelets to various agonists. Ossabaw 
swine develop all the hallmarks of MetS including obesity, insulin resistance, hypertension, 
dyslipidemia, endothelial dysfunction, and coronary artery disease when being fed excess calo-
rie atherogenic diet. We hypothesized that Ossabaw swine with MetS would exhibit increased 
platelet reactivity compared with lean pigs without MetS.
Materials and methods: Ossabaw swine were fed high caloric, atherogenic diet for 44 weeks 
to induce MetS (n = 10) and were compared with lean controls without MetS that had been 
fed normal calorie standard diet (n = 10). Light transmittance aggregometry was performed 
using adenosine diphosphate (ADP), collagen, thrombin, and arachidonic acid (AA) at different 
concentrations. Dose response curves and EC50 were calculated. Glucose tolerance testing and 
intravascular ultrasound study of coronary arteries were performed.
Results: MetS pigs compared with lean controls were morbidly obese, showed evidence of 
arterial hypertension, elevated cholesterol, low-density lipoprotein/high-density lipoprotein, 
and triglycerides, and insulin resistance. Platelets from MetS pigs were more sensitive to ADP-
induced platelet aggregation than leans (EC50: 1.83 ± 1.3 µM vs 3.64 ± 2.2 µM; P = 0.02). 
MetS pigs demonstrated higher platelet aggregation in response to collagen than lean pigs (area 
under the curve: 286 ± 74 vs 198 ± 123; P = 0.037) and a trend for heightened response to AA 
(AUC: 260 ± 151 vs 178 ± 145; P = 0.13). No significant difference was found for platelet 
aggregation in response to thrombin.
Conclusions: MetS in Ossabaw swine is associated with increased reactivity of platelets to 
ADP and collagen. The Ossabaw swine may be a practical, large animal model for the study 
of certain aspects of platelet pathophysiology and examine vascular devices in a metabolic 
environment comparable to humans with MetS.
Keywords: coronary artery disease, insulin resistance, glucose intolerance, platelet
Introduction
The term metabolic syndrome (MetS) has been used to describe the combination and 
  co-occurrence of abdominal obesity, insulin resistance, impaired glucose tolerance, 
hypertension, and dyslipidemia (increased low-density lipoprotein/high-density lipo-
protein [LDL/HDL] and triglycerides). These cardiovascular risk factors interact with 
each other and accelerate the progression of atherosclerosis and arterial thrombosis.1–3 
Although MetS is considered to represent heterogeneous traits, insulin resistance 
and glucose intolerance associated with obesity are considered to be central to the 
pathophysiology. MetS depends on genetic predisposition, as well as environmental 
conditions that allow its progression. An abundant high-calorie, high-fat diet, and Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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sedentary lifestyle are considered central to the development 
of MetS in individuals at risk. Estimates suggest that approxi-
mately 24% of   Americans suffer from MetS as defined by 
Adult Treatment Panel III (ATP III) guidelines.4 The onset of 
MetS and further progression to type 2 diabetes is associated 
with findings of endothelial dysfunction, increased platelet 
activation, and platelet hyperreactivity.1,5–9
The Ossabaw miniature swine has recently been identified 
as a large animal model for the study of the pathogenesis of 
MetS.10,11 Ossabaw swine, from Ossabaw Island off the coast 
of Georgia, exhibit a thrifty genotype, which allows them 
to store large amounts of fat for survival during seasonal 
famine accentuated by the isolated location of the island. 
When fed an excess calorie atherogenic diet over several 
months, Ossabaw swine develop all the pathological aspects 
of MetS, including hypertension, dyslipidemia, glucose 
intolerance, endothelial dysfunction, steatohepatitis, as well 
as atherosclerosis in the coronary vasculature.10–20
So far no study has examined the effects of MetS in 
Ossabaw swine on platelet aggregation. We hypothesized 
that Ossabaw swine with MetS exhibit a pro-aggregatory 
phenotype evidenced by increased reactivity of platelets to 
agonists compared with lean pigs without MetS.
Materials and methods
All experimental procedures involving animals were approved 
by the Indiana University Animal Care and Use Committee and 
complied fully with the Guide for the Care and Use of Labora-
tory Animals and the American Veterinary Medical Associa-
tion Panel on Euthanasia.21,22 For all surgical procedures and 
euthanasia, anesthesia was induced by tiletamine-zolazepam 
(5 mg/kg) and xylazine (2.2 mg/kg) given intramuscularly; 
anesthesia was maintained with isoflurane gas (,4%). Pigs 
were euthanized by cardiectomy while anesthetized.
Metabolic syndrome pig model
Ossabaw miniature swine (Sus scrofa) were provided from 
the colony in the Comparative Medicine Program of Indiana 
University School of Medicine and Purdue University. Swine 
aged 6 to 7 months at the beginning of the study were fed for 44 
weeks either a lean standard chow of 2400 kCal/day containing 
8% fat (lean control group, n = 10) or an excess calorie athero-
genic diet of 6000 kcal/day containing 45% fat (MetS group, 
n = 10).17 The details of this pig model, including the composi-
tion of the atherogenic diet (5B4L; Purina TestDiet, Richmond, 
IN) and lean standard chows (5L80; Purina TestDiet) have been 
published previously.17 In this model, total cholesterol increased 
about 5-fold and triglycerides about 3-fold.
Body weights were measured on a weekly basis in all 
animals. Blood pressure was measured with a tail cuff 
sphygmomanometer in conscious swine in a low-stress 
restraint sling.10,11
intravenous glucose tolerance test
Swine were acclimatized to low-stress restraint in a specialized 
sling for 5 to 7 days before the intravenous glucose tolerance 
test (IVGTT).10,11 Swine were then fasted overnight and after 
inducing anesthesia, the right jugular vein was catheterized 
percutaneously.10,11 As previously described and after collecting 
fasting blood samples, pigs were administered an intravenous 
bolus of 1 g glucose/kg body weight, and blood samples 
were obtained at 5, 10, 20, 30, 40, 50, and 60 minutes after 
injection.10,11 Blood glucose was measured using a YSI 2300 
Stat Plus analyzer (YSI, Yellowsprings, OH). Plasma insulin 
levels were determined as previously described.11 The area 
under the curve (AUC) was calculated with the baseline at 0.
Plasma lipids
Fasting plasma samples obtained the day of the IVGTT from 
the jugular catheter were analyzed for triglycerides, total 
cholesterol and HDL fraction by using a standard enzymatic 
kit (Thermo Trace, Melbourne, Australia) as previously 
described.11 LDL was calculated using the Friedewald equa-
tion (LDL = total cholesterol – HDL – (triglycerides/5)).
intravascular ultrasound
Intravascular ultrasound (IVUS) study of both left anterior 
descending and circumflex coronary arteries using a 30 or 
40 MHz IVUS imaging catheter (Ultracross 3.2 or Discovery; 
Boston Scientific, Natick, MA) was performed as previously 
described.10–13,15,16,18 Atheroma was defined as the presence 
of soft or fibrous plaque adjacent to the lumen and sepa-
rated from the adventitia by an echolucent medial layer as 
previously described.10–13,15,16,18 All segments were analyzed 
at 1-mm intervals along the length of the arteries. Percent 
degrees atheroma (% circumferential wall coverage) was 
calculated and compared between groups.
Platelet aggregation
Whole blood (60–70 mL) was collected from large bore cen-
tral catheters into vacutainers containing 3.2% citrate prior to 
administration of heparin or contrast material and was used 
immediately for platelet experiments. Platelet-rich plasma 
(PRP) was obtained from citrate blood after centrifugation 
at 120 g for 5 minutes. After recovering the PRP, the blood 
samples were subjected to further centrifugation at 850 g Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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for 10 minutes to recover platelet-poor plasma (PPP). The 
resulting PRP and PPP were kept at room temperature for 
use within 1 hour. Platelets were stimulated at 37°C with 
adenosine diphosphate (ADP) at concentrations of 0.5, 1, 
2.5, 5, 10, and 20 µM, collagen at 1 µg/mL and arachidonic 
acid (AA) at 0.5 mM (Chrono-log Corporation, Havertown, 
PA) as previously described.23 Thrombin was chosen over 
thrombin receptor agonist peptide (TRAP) as agonist due 
to inability of TRAP to induce consistent aggregation of 
porcine platelets by activation of platelet protease activated 
receptor-1 (PAR1).24
Platelets for thrombin experiments were washed by 
further centrifugation of PRP at 850 g for 10 minutes to 
remove plasma and reduce fibrin formation induced by 
thrombin during platelet aggregation. The supernatant was 
discarded and the remaining pellet resuspended in HEPES 
buffer (Sigma-Aldrich, St. Louis, MO) at a platelet concen-
tration of 100 × 106/mL. Aggregation of washed platelet 
suspension was measured after stimulation with thrombin 
(Chrono-log Corporation) at concentrations of 0.01, 0.05, 
0.1, and 0.5 U/mL.
Aggregation measurements were performed with a 
Chronolog Lumi-Aggregometer (model-700; Chrono-log 
Corporation) with the AggroLink software package as 
described previously.23 Platelet aggregation was expressed 
as the maximal percent change in light transmittance from 
baseline (MPA) or as AUC within 8 minutes, using animal 
specific PPP or HEPES buffer as a reference.
Dose response curves and half maximal effective con-
centrations (EC50) were calculated for each animal using 
single ligand regression analysis for the different agonist 
concentrations of thrombin and ADP.
Statistical analysis
All statistical analyses were performed using Sigma Plot 
  (version 11; Systat Software, San Jose, CA) and SPSS sta-
tistics (version 18; SPSS Inc., Somers, NY). As appropriate, 
t-tests were used to compare platelet aggregation between 
groups and means of EC50, with P , 0.05 considered 
significant. Wilcoxon rank-sum test was used to compare 
nonparametric data. Single ligand regression analysis was 
performed to calculate EC50 for ADP and thrombin. Unless 
specified otherwise, values are represented as means ± 
standard deviation (SD).
Results
Metabolic syndrome characteristics
Swine fed high calorie, high fat/cholesterol/fructose athero-
genic diet were considerably more obese than those fed 
standard chow (107.5 ± 8.7 vs 65.8 ± 6.7 kg, P , 0.01) 
and exhibited all the features of MetS compared with lean 
controls (Figure 1, Table 1).
Both systolic and diastolic hypertension were present in 
MetS pigs compared with lean controls (148/95 mmHg vs 
126/80 mmHg, P , 0.01). Total cholesterol was almost 
4-fold higher and triglycerides were roughly 2-fold increased 
in obese pigs compared with lean controls. Obese pigs with 
Figure 1 Ossabaw swine phenotypes and coronary atherosclerosis. Lean (A) and 
obese, metabolic syndrome (B) swine; (C) coronary atheroma visualized in an 
animal with metabolic syndrome by intravascular ultrasound with arrows indicating 
neointimal border (inT) and external elastic membrane (eeM).
Table 1 Metabolic syndrome characteristics: animal body weight, systolic and diastolic blood pressure measurements, lipid profiles, 
insulin  area  under  the  curve  (AUc)  concentration  during  intravenous  glucose  tolerance  test  and  percentage  of  circumferential 
atherosclerosis coverage on intravascular ultrasound evaluation of left anterior descending and circumflex arteries (mean ± SD)
  Metabolic syndrome (n = 10) Lean (n = 10) P value
Body weight (kg) 107.5 ± 8.7 65.8 ± 6.7 ,0.01
Systolic blood pressure (mmhg) 148 ± 1 126 ± 2 ,0.01
Diastolic blood pressure (mmhg) 95 ± 1 80 ± 2 ,0.01
cholesterol (mg/dL) 220 ± 174 60.9 ± 9 0.025
Triglycerides (mg/dL) 56 ± 16 26 ± 8 ,0.01
LDL (mg/dL) 161 ± 152 17.4 ± 9 0.016
hDL (mg/dL) 36 ± 11 38 ± 7 0.68
LDL/hDL ratio 3 ± 1.2 0.5 ± 0.3 ,0.01
insulin AUc (µU/mL) 8596 3643 ,0.00001
circumferential coronary  
atherosclerosis coverage (%)
33 ± 2% 25 ± 2% 0.013
Abbreviations: hDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; SD, standard deviation.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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MetS showed an almost 10-fold increase in LDL levels 
compared with lean controls with similar concentrations of 
HDL (Table 1).
MetS pigs demonstrated insulin resistance as evidenced 
by higher insulin concentrations and higher glucose con-
centrations following IVGTT (Table 1, Figure 2). It is 
noteworthy that animals with MetS exhibited significantly 
higher levels of insulin than leans even before administration 
of intravenous glucose bolus.
Intravascular ultrasound showed larger coronary ather-
oma volume as defined by percent circumferential wall cov-
erage in obese pigs with MetS compared with lean controls 
(33 ± 2% vs 25 ± 2%, P = 0.013). An example of a coronary 
atheroma from a MetS animal is depicted in Figure 1.
Platelet aggregation
Platelet aggregation results for increasing doses of ADP 
(Figure 3) and for thrombin as agonists (Figure 4) are shown. 
MetS animals showed a trend towards higher maximal platelet 
aggregation at submaximal concentrations of ADP, compared 
with leans with similar aggregation at maximal concentra-
tions of ADP. For both ADP and thrombin EC50 were calcu-
lated for each sample using single ligand regression analysis. 
Overall, platelets from pigs with MetS were more sensitive 
to aggregation by ADP than platelets from lean controls with 
lower EC50 concentration (EC50 [MPA]: 1.83 ± 1.3 µM vs 
3.64 ± 2.2 µM; P = 0.02) (Figure 5). Higher velocity of 
platelet aggregation as defined by the slope of initial aggrega-
tion was measured for submaximal concentrations of ADP in 
animals with MetS vs lean controls with similar velocity for 
maximal concentrations of ADP (EC50 [slope]: 1.06 ± 0.9   
µM vs 2.42 ± 1.6 µM; P = 0.02) (Figures 3, 5). There was 
a nonsignificant trend towards lower EC50: (0.27 ± 0.3 vs 
0.36 ± 0.6 U/l; P = 0.36) (Figure 5) for aggregation induced 
by thrombin in platelets from MetS pigs compared with lean 
controls. No significant difference was found for slope of 
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thrombin-induced platelet aggregation between MetS and 
lean controls (data not shown). Obese pigs with MetS dem-
onstrated higher platelet aggregation in response to collagen 
than lean pigs (AUC: 286 ± 74 vs 198 ± 123; P = 0.037) and 
a trend towards higher platelet aggregation in response to AA 
(AUC: 260 ± 151 vs 178 ± 145; P = 0.13) (Figure 4).
Discussion
Obesity and MetS are important cardiovascular risk factors 
involved in the development of atherosclerotic disease. It is 
well established that insulin resistance and the emergence of 
diabetes mellitus are associated not only with atherosclerotic 
plaque formation and progression, but also influence the 
thrombotic phenotype of affected individuals.1,5–9 Numerous 
studies have documented that patients with diabetes melli-
tus exhibit higher levels of activated platelets and are more 
likely to show inadequate inhibition of platelet aggregation 
by aspirin or thienopyridines.25–27 As platelets become acti-
vated they form aggregates with leukocytes through binding 
by p-selectin and experience cross talk with leukocytes that 
leads to secretion of tissue factor by leukocytes and genera-
tion of thrombin.28,29 Platelet–leukocyte aggregates that are 
increased in patients with diabetes mellitus promote rolling 
and delivery of leukocytes to the endothelium and promote 
transmigration of leukocytes, and may thus promote vascular 
inflammation and atherosclerosis formation.1,8,28,29 Consistent 
with these ex vivo findings, patients with coronary disease 
and diabetes mellitus are at highest risk for recurrent myo-
cardial infarction and stent thrombosis after percutaneous 
coronary interventions and more likely to be clopidogrel 
‘nonresponders’ than nondiabetic patients.30
Several mechanisms have been postulated to play a role in 
increasing platelet reactivity associated with MetS, including 
direct effects of free fatty acids, adiponectin, and leptin on 
platelets.1,31,32 A recent study examining the effect of weight 
loss suggested altered platelet inhibitory effects of nitric 
oxide and prostacyclin in obese individuals.33 Also, previous 
studies have suggested that insulin resistance may lead to a 
loss of insulin-mediated inhibition of P2Y12 receptor signal-
ing, thereby increasing ADP-mediated platelet aggregation.34 
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Platelets from obese Ossabaw swine with MetS were more 
sensitive to lower doses of ADP as defined by a lower EC50 
concentration and showed evidence of faster initial platelet 
aggregation in response to submaximal concentrations of 
ADP. Similarly, higher platelet aggregation was shown in 
platelets from MetS pigs compared with platelets from lean 
controls when using a fixed concentration of collagen and 
AA as agonist. The molecular mechanisms responsible for 
this effect remain unclear. It can be deduced, however, that 
platelets from animals with MetS may have a higher tendency 
for aggregation under shear conditions than platelets from 
animals without MetS.
Although numerous rodent and small animal models are 
available for atherosclerosis research, we still lack large animal 
models that allow study of the progression of atherosclerosis 
and use of experimental devices in human-sized animals.35 
Other miniature swine models of MetS are limited by lack of 
hypertension and also coronary atherosclerosis has not been 
documented.36 The Ossabaw swine model has appeared as a 
viable option for the study of coronary interventional devices 
and coronary disease in an animal that is close to human size 
and exhibits the same metabolic changes that are associated 
with vascular disease in the human population.10–18 Within our 
study Ossabaw swine who were fed excess calorie atherogenic 
diet for 44 weeks developed all the features of MetS compared 
with a lean control group, including central abdominal obesity, 
systolic and diastolic hypertension, hypertriglyceridemia, 
hypercholesteremia, insulin resistance, impaired glucose 
tolerance, and coronary atherosclerosis.
The effect of type 1 diabetes mellitus on platelet aggre-
gation has been studied in swine models.37 This is the first 
study to examine the platelet aggregatory phenotype of obese 
Ossabaw swine with MetS and insulin resistance compared 
with non-MetS pigs. Shukla et al included an atherogenic 
diet fed group of Sinclair miniature swine, who failed to 
show increased platelet reactivity, although that group was 
dyslipidemic, similar to the MetS Ossabaw swine in the cur-
rent study.37 Thus, the increased sensitivity of MetS Ossabaw 
platelets to ADP and collagen may potentially be due to other 
factors in MetS, such as insulin resistance. Clearly, this is 
a highly distinguishing feature of Ossabaw miniature swine 
compared with Sinclair or Yucatan swine, which do not show 
primary insulin resistance when fed excess calorie diet.20,35
Conclusions
This study adds additional information to the phenotypic 
characterization of the obese Ossabaw swine and suggests 
the presence of a pro-aggregatory environment in Ossabaw 
swine with MetS that may be comparable to humans with 
MetS. Combined with the finding of spontaneous coronary 
atherosclerosis in obese Ossabaw swine, these data support 
the use of this model to study intravascular devices in a 
metabolic environment comparable to human patients with 
MetS. The obese Ossabaw swine may be an ideal large ani-
mal model for the study of the effects of high caloric-high 
fat diet on the genesis of MetS and may be useful to further 
examine the mechanisms associated with increased platelet 
reactivity in humans with MetS.
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